Thank you very much.
Thank you to both of you for being here. I do hope we get Dr. Pai back because some of my questions were specifically for him.
I'll start with Professor Gagnon, although some of my questions were specifically for Dr. Pai. Just going back through some of the testimony, I know that Dr. Pai had mentioned that Canada has only contributed 15 million vaccines, but in fact, there's an additional 87 million doses that have already gone to the global south and are in people's arms because of the cash equivalence. That also includes the syringes, which we heard of in previous testimony.
That's not my specific question. It's more about all of the other things. This is about so much more than doses. For instance, when you look at manufacturing capacity, Canada is partnering with South Africa on the COVAX manufacturing task force to look at that as a pilot project. I'd be interested in your views on that. There's the fact that a lot of countries need assistance with regulatory processes, with procurement processes and with their communication with their public. One of the examples is $50 million that Canada has provided to the Pan American Health Organization. With regard to what Dr. Fry mentioned about testing, treating and health systems, Canada is either first or second to the ACT accelerator in each of those areas.
My specific question is really on this idea that somehow we haven't learned from this process and that if there's a future pandemic, we wouldn't do any better. The fact is that there's almost $300 million in budget 2022, additional money on top of the $2.7 billion we've already provided, that's specifically for health systems. We heard previous testimony that health systems are the biggest indicator of the countries that either failed or succeeded.
Can you comment on the support that Canada has given in all of these other areas—more than other countries—and also the support we are now committing to for improving health systems in future pandemics?